Related Experiment Video
Updated: Oct 24, 2026

Development and Characterization of Fusidic Acid-Loaded Alginate-Aloe vera Based Hydrogel Film
Published on: December 13, 2024
Wet-Adhesive Hydrogel Patch for Sustained Oral Ulcer Treatment
Yue Dong1, Mengya Li2, Chenyu Yang1
1School of Science and Engineering, The Chinese University of Hong Kong (Shenzhen), Shenzhen, Guangdong518172, China.
Abstract:
Oral ulcers are a common mucosal disorder that causes persistent pain and significantly impairs quality of life for patients. Current therapeutic approaches, including sprays and commercial patches, provide only temporary relief, as the complex, dynamic, and moist oral environment hinders prolonged retention and drug efficacy. Here, we report the rational design of a multifunctional hydrogel adhesive that integrates poly(acrylic acid) (PAA) for hydrogen bonding, polyamidoamine-epichlorohydrin (PAE) for electrostatic interactions with mucosal surfaces, and poly(methyl methacrylate) (PMMA) for swelling resistance. The resulting hydrogel exhibits an instant wet tissue adhesion strength of ∼40 kPa and enhances adhesion after prolonged immersion in phosphate-buffered saline (PBS). Remarkably, it retains high adhesion strength under extreme conditions, such as hypertonic and strongly acidic environments. When loaded with dexamethasone acetate, the hydrogel enables controlled drug release, significantly improving therapeutic outcomes in a rat oral ulcer model. By ensuring prolonged retention and effective drug delivery, this hydrogel patch offers a promising strategy for enhancing oral ulcer treatment.
Related Concept Videos
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Ophthalmic Drug Delivery Systems
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Oral Drug Delivery Systems: Continuous-Release Systems
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Oral Drug Delivery Systems: Delayed-Release Systems